Yesterday, FDA announced modifications to the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone (Mifeprex–Danco Labs) that enable pharmacies to become certified to dispense this FDA-approved drug to patients with a prescription, as long as they comply with the certification requirements.

WASHINGTON, D.C. – The American Pharmacists Association (APhA) today hailed the release of a peer-reviewed study that found that community-based pharmacists and their teams administered more than 270 million COVID-19 vaccinations in community pharmacies alone through September 2022.

The National Community Pharmacists Association (NCPA),  the American Pharmacists Association (APhA) and the National Association of Chain Drug Stores (NACDS), along  with American Pharmacies (APRx) and the Oklahoma Pharmacists Association (OPhA)